NOTICE: Board of Registration in Podiatry Permanently Adopts Emergency Regulations Regarding Hydrocodone-only Extended Release Medication (Zohydro ER)

September 12, 2014

On August 19, 2014, the Board of Registration in Podiatry (the “Board”) voted to permanently adopt emergency regulations on Hydrocodone-only Extended Release Medication (Zohydro ER), previously approved at the Board’s May 13, 2014 meeting. The regulations place restrictions on the ability of licensed podiatrists to prescribe hydrocodone-only extended release medication that is not in an abuse deterrent form (commonly known as Zohydro ER), and will take effect on September 12, 2014.

The regulations require licensed podiatrists to complete a risk assessment of each patient prior to prescribing any patient hydrocodone-only extended-release medication that is not in abuse-deterrent form. In most cases, the podiatrist must also enter into a pain management treatment agreement with the patient that addresses drug screening, pill counts, safe storage and disposal, and other requirements as appropriate in the prescriber’s judgment. In addition, the regulations also require licensed podiatrists to complete a continuing education course in opiate education.

The regulations amend 249 CMR 3.00 - 4.00 and contain only minor revisions to the prior, emergency regulations promulgated by the Board on May 19, 2014. Copies of the final regulations are available through the links below: